Murugan Natarajan

465 total citations
10 papers, 297 citations indexed

About

Murugan Natarajan is a scholar working on Infectious Diseases, Epidemiology and Genetics. According to data from OpenAlex, Murugan Natarajan has authored 10 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in Murugan Natarajan's work include Mycobacterium research and diagnosis (5 papers), COVID-19 Clinical Research Studies (4 papers) and Leprosy Research and Treatment (3 papers). Murugan Natarajan is often cited by papers focused on Mycobacterium research and diagnosis (5 papers), COVID-19 Clinical Research Studies (4 papers) and Leprosy Research and Treatment (3 papers). Murugan Natarajan collaborates with scholars based in India, Netherlands and Belarus. Murugan Natarajan's co-authors include Karthick Rajendran, A Ramachandran, K. Narayanasamy, K Katoch, Ankush Bhatia, Vishwa Mohan Katoch, Santhosh Sigamani, A. Priyadharsan, Chinnaperumal Kamaraj and Govindasamy Balasubramani and has published in prestigious journals such as Transplantation, American Journal of Tropical Medicine and Hygiene and Journal of Medical Virology.

In The Last Decade

Murugan Natarajan

10 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Murugan Natarajan India	5	239	82	33	25	24	10	297
K. Narayanasamy India	5	216 0.9×	81 1.0×	33 1.0×	25 1.0×	23 1.0×	22	316
Yunsuk Cho South Korea	9	314 1.3×	99 1.2×	52 1.6×	27 1.1×	37 1.5×	15	415
Yujin Sohn South Korea	9	326 1.4×	104 1.3×	55 1.7×	28 1.1×	38 1.6×	20	434
Pedram Habibi Iran	5	144 0.6×	44 0.5×	14 0.4×	24 1.0×	18 0.8×	8	216
Hossein Chiti Iran	4	140 0.6×	43 0.5×	19 0.6×	19 0.8×	14 0.6×	5	251
Mayu Ikeda Japan	3	217 0.9×	68 0.8×	14 0.4×	44 1.8×	22 0.9×	3	263
Costanza Di Chiara Italy	10	135 0.6×	46 0.6×	19 0.6×	8 0.3×	15 0.6×	33	246
Süda Tekin Türkiye	9	141 0.6×	77 0.9×	22 0.7×	16 0.6×	12 0.5×	34	244
Luis Unigarro Ecuador	3	176 0.7×	61 0.7×	12 0.4×	25 1.0×	32 1.3×	5	308
Doménica Cevallos-Robalino Ecuador	4	178 0.7×	60 0.7×	12 0.4×	25 1.0×	32 1.3×	5	314

Countries citing papers authored by Murugan Natarajan

Since Specialization

Citations

This map shows the geographic impact of Murugan Natarajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murugan Natarajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murugan Natarajan more than expected).

Fields of papers citing papers by Murugan Natarajan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murugan Natarajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murugan Natarajan. The network helps show where Murugan Natarajan may publish in the future.

Co-authorship network of co-authors of Murugan Natarajan

This figure shows the co-authorship network connecting the top 25 collaborators of Murugan Natarajan. A scholar is included among the top collaborators of Murugan Natarajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murugan Natarajan. Murugan Natarajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Natarajan, Gopalakrishnan, et al.. (2023). Clinico-Epidemiological Profile of COVID-19 Patients with Omicron Variant Admitted in a Tertiary Care Center, South India. International Journal of General Medicine. Volume 16. 185–191. 1 indexed citations

Ragavendran, Chinnasamy, Chinnaperumal Kamaraj, A. Priyadharsan, et al.. (2023). Phyto-fabrication of AgNPs using leaf extract of Vitex trifolia: potential to antibacterial, antioxidant, dye degradation, and their evaluation of non-toxicity to Chlorella vulgaris. Biomass Conversion and Biorefinery. 14(13). 14903–14920. 12 indexed citations

Sankaranarayanan, Krishnan, et al.. (2021). Etiological profile of diarrhea in solid organ transplant recipients at a tertiary care center in Southern India. Transplant Infectious Disease. 23(4). e13584–e13584. 3 indexed citations

Hussain, Sajid, et al.. (2021). Profile of COVID-19 Patients at Zero Delay COVID-19 Ward, in a Tertiary Care Hospital in South India. Journal of Primary Care & Community Health. 12. 3667720662–3667720662. 2 indexed citations

Rajendran, Karthick, et al.. (2020). Convalescent plasma transfusion for the treatment of COVID‐19: Systematic review. Journal of Medical Virology. 92(9). 1475–1483. 228 indexed citations

Narayanasamy, K., Murugan Natarajan, A Ramachandran, et al.. (2020). Clinical Outcomes among Asymptomatic or Mildly Symptomatic COVID-19 Patients in an Isolation Facility in Chennai, India. American Journal of Tropical Medicine and Hygiene. 104(1). 85–90. 27 indexed citations

Natarajan, Murugan, et al.. (2014). Role of Quantiferon TB Test in Identifying Patients at Risk For Reactivation of Tuberculosis in Liver Transplant Recipients in an Endemic Setting.. Transplantation. 98. 166–166. 1 indexed citations

Katoch, K, et al.. (2010). Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.. PubMed. 80(4). 331–44. 8 indexed citations

Katoch, K, et al.. (2000). Chemotherapy trial in paucibacillary leprosy using clofazimine.. PubMed. 71(3). 311–24. 11 indexed citations

10.

Katoch, K, Murugan Natarajan, Ankush Bhatia, & V S Yadav. (1992). Treatment of paucibacillary leprosy with a regimen containing rifampicin, dapsone and prothionamide.. PubMed. 64(3). 303–12. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact